GLS and ovarian carcinoma: Furthermore, we found that compound 968, as an inhibitor of glutaminase, was able to inhibit cell proliferation, which was consistent with the findings of Yuan and co-workers who reported that compound 968 inhibited cell proliferation and sensitized cells to paclitaxel treatment in ovarian cancer [19].